Elisabeth Bjork

Insider Reports History

Location
C/O Rocket Pharmaceuticals, Inc., 350 Fifth Avenue, Suite 7530, New York, NY
Signature
/s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elisabeth Bjork:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Director Common Stock 40K $136K $3.41 Aug 27, 2025 Direct
ROCKET PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 607 $9.13K $15.04 Sep 26, 2024 Direct

Insider Reports Filed by Elisabeth Bjork

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCKT ROCKET PHARMACEUTICALS, INC. Aug 27, 2025 1 $34.1K 4 Aug 27, 2025 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 18, 2025 1 $0 4 Jul 18, 2025 Director
RCKT ROCKET PHARMACEUTICALS, INC. Sep 26, 2024 1 $0 4 Oct 29, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2024 2 $50K 4 Jun 20, 2024 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 22, 2023 2 $50K 4 Jun 26, 2023 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 13, 2022 2 $49.9K 4 Jun 15, 2022 Director
RCKT ROCKET PHARMACEUTICALS, INC. Jun 14, 2021 2 $50K 4 Jun 16, 2021 Director